Skip to main content
Arjan Diepstra
dr.

As a hematopathologist, I work on diagnostics of all types of hematological malignancies using a comprehensive panel of different techniques. Moreover, my main research interest involves Hodgkin lymphoma, with a strong focus on interactions between tumor cells and the microenvironment. In addition, I also have a long standing interest in genetic susceptibility. My areas of expertise are: immunology, tumor cell biology, genetic association studies and molecular diagnostics in pathology. I actively participate in international (EORTC) and national (HOVON) clinical trials.

Antibody-mediated targeting of CD45 isoforms: A novel immunotherapeutic strategy
CD45 is a family of transmembrane protein tyrosine phosphatases exclusively expressed by hematopoietic cells and critically involved in the regulation of T cell activation signals, We now demonstrate that three 100-mu g doses of antiCD45RB mAb MB23G2 can induce long-term engraftment of islets into major histcompatibility complex-disparate chemically diabetic mice, Long-term graft survivors (>120 days) were tolerant to new islet allografts from the original donor strain, MB23G2 induced a temporary decrease in number circulating leukocytes but had no effect on leukocyte number in other lymphoid compartments, Histologic examination...
GP Basadonna, L Auersvald, CQ Khuong, N Kashio, D Zekzer, M Minozzo, HY Qian, L Visser, A Diepstra, AI Lazarovits, S Poppema, TB Strom, DM Rothstein